NCT00291473: Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers |
|
|
| Completed | 1 | 9 | Japan | CHP-HER2, CHP-NY-ESO-1 | Ludwig Institute for Cancer Research, Mie University | Esophageal Cancer, Lung Cancer, Stomach Cancer, Breast Cancer, Ovarian Cancer | 08/08 | 08/08 | | |